About Helios Cardio
Helios Cardio is a Healthcare company based in Weston (United States) founded in 2019. It develops biologic matrices for cardiac repair and regeneration of heart conditions. It operates on a B2B model. Helios Cardio offers products and services including Fetal Engineered Biologic Matrix (f-EBM) and CardiaMendâ„¢. Its focus areas include Medical Devices, Cardiovascular, Regenerative Medicine and Health Tech. Its legal entity is Helios Cardio Inc. Its competitors include Atraverse Medical, ValCor Cath and Terumo Cardiovascular Group; 2 of its 3 listed competitors have raised funding.
Company details
Helios Cardio is a company focused on advancing regenerative medicine for cardiovascular diseases, including heart failure and complications from surgery. They create innovative biologic tissue scaffolds like f-EBM to support tissue repair and reconstruction. Based in Weston, Massachusetts, USA, the company collaborates with medical professionals and researches combinations with stem cells and drugs. Their efforts aim to address unmet needs in cardiac health through FDA-cleared devices.
- Headquarters Weston, United States
- SectorsHealthcare
- Phone•••• ••••
- Website helioscardio.com
- Social LinkedIn X
- Legal Name Helios Cardio Inc
Products & Services of Helios Cardio
Helios Cardio offers a comprehensive portfolio of products and services, including Fetal Engineered Biologic Matrix (f-EBM) and CardiaMend™.
Provides cell-friendly environment for cardiac tissue regeneration and repair.
Supports pericardial and epicardial repair with high biocompatibility properties.
Competitors of Helios Cardio
Helios Cardio has 3 listed competitors in our database, 2 of them funded. They include Atraverse Medical, ValCor Cath and Terumo Cardiovascular Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atraversemedical.com | 2022 | Chicago, United States | $61.9M | Next-generation tools for left-heart access are developed for cardiac treatments. | ||
| 2023 | Toledo, United States | $1.07M | Medical devices for cardiac surgeries are developed. | |||
| terumo-cvs.com | 1999 | Ann Arbor, United States | Produces high-quality devices for a wide range of cardiovascular surgeries. |
Detailed competitors of Helios Cardio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Organ-on-Chip & Regenerative Solutions
3 companies that operate in the same segment as Helios Cardio (Organ-on-Chip & Regenerative Solutions) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Synthetic adhesives for bone and dental repair are developed. | 2014 | Lowell, Massachusetts, United States | USD 24.42 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Helios Cardio
Helios Cardio was founded in 2019.
Helios Cardio is headquartered in Weston, United States. It is registered at Weston, Florida, United States.
Helios Cardio is a company focused on advancing regenerative medicine for cardiovascular diseases, including heart failure and complications from surgery. They create innovative biologic tissue scaffolds like f-EBM to support tissue repair and reconstruction. Based in Weston, Massachusetts, USA, the company collaborates with medical professionals and researches combinations with stem cells and drugs. Their efforts aim to address unmet needs in cardiac health through FDA-cleared devices.
Helios Cardio's top competitors include Atraverse Medical, ValCor Cath and Terumo Cardiovascular Group.
Helios Cardio offers Fetal Engineered Biologic Matrix (f-EBM) and CardiaMendâ„¢.
Helios Cardio operates through Helios Cardio Inc.